Octarine is a biopharmaceutical firm that researches and develops cannabinoid and psilocybin derivatives to healthcare industries.
Business Model:
Revenue: $0
Employees: 1-10
Address: Howitzvej
City: Copenhagen
State: south denmark
Zip: 2000
Country: DK
Octarine is a biopharmaceutical firm that researches and develops cannabinoid and psilocybin derivatives to healthcare industries.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2020 | Non Equity Assistance | 1 | - |
MassChallenge MassChallenge |
9/2022 | Pre-Series A | $2M |
DSM venturing Oskare Capital |
9/2022 | Seed Round | $0 |
DSM Venturing Oskare Capital DSM Venturing Oskare Capital |
1/2020 | Equity | - | 3/2021 | Seed | 2 | $1.2M |
Oskare Capital Vaekstfonden Oskare Capital Vaekstfonden |
11/2020 | Seed Round | 4 | $1.8M |
Bruce Linton Enexis AB Oskare Capital Vaekstfonden Bruce Linton Enexis AB Oskare Capital Vaekstfonden |
1/2020 | Pre Seed Round | 2 | - |
Bruce Linton Oskare Capital Bruce Linton Oskare Capital |
11/2020 | Seed | - |
Danish State Growth Fund Enexis AB, Oskare Capital Danish State Growth Fund Enexis AB, Oskare Capital |
3/2020 | Equity | - |
Vaekstfonden Vaekstfonden |
1/2020 | Equity | - | 9/2022 | Seed Round | 2 | $2M |
DSM Venturing Oskare Capital DSM Venturing Oskare Capital |
10/2020 | Non Equity Assistance | 1 | - |
MassChallenge MassChallenge |
1/2020 | Pre Seed Round | 2 | - |
Bruce Linton Oskare Capital Bruce Linton Oskare Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|